These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 3458190)
21. PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets. Bryckaert MC; Rendu F; Tobelem G; Caen J Biochem Biophys Res Commun; 1986 Feb; 135(1):52-7. PubMed ID: 3006686 [TBL] [Abstract][Full Text] [Related]
22. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors. Kobzar G; Mardla V; Samel N Platelets; 2011; 22(5):338-44. PubMed ID: 21557683 [TBL] [Abstract][Full Text] [Related]
23. Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets. Authi KS; Evenden BJ; Crawford N Biochem J; 1986 Feb; 233(3):707-18. PubMed ID: 2939827 [TBL] [Abstract][Full Text] [Related]
24. Interaction of rat platelets with Listeria monocytogenes. Czuprynski CJ; Balish E Infect Immun; 1981 Jul; 33(1):103-8. PubMed ID: 6790437 [TBL] [Abstract][Full Text] [Related]
25. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin. Wong PC; Jiang X Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316 [TBL] [Abstract][Full Text] [Related]
26. Ditazole and platelets. I. Effect of ditazole on human platelet function in vitro. De Gaetano G; Tonolli MC; Bertoni MP; Roncaglioni MC Haemostasis; 1977; 6(2):127-36. PubMed ID: 16812 [TBL] [Abstract][Full Text] [Related]
27. The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine. Nylander M; Lindahl TL; Bengtsson T; Grenegård M Platelets; 2008 Aug; 19(5):352-8. PubMed ID: 18791941 [TBL] [Abstract][Full Text] [Related]
28. Unsaturated 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholines (unsaturated platelet-activating factor): aggregation of human platelets after incubation with indomethacin, creatinephosphate/creatinephosphokinase, xylocain and hirudine, and serotonin release after incubation with indomethacin. Korth R; Mangold HK; Muramatsu T; Zöllner N Chem Phys Lipids; 1985 Jan; 36(3):209-14. PubMed ID: 4006034 [TBL] [Abstract][Full Text] [Related]
29. [The role of thrombocyte prostanoids and products secreted by dense granules in the platelet attachment, spreading and aggregation on collagen substrates]. Leĭtin VL; Missel'vits F; Liubimova EV; Domogatskiĭ SP Biokhimiia; 1989 Nov; 54(11):1804-14. PubMed ID: 2516746 [TBL] [Abstract][Full Text] [Related]
30. Formation of PI 3-kinase products in platelets by thrombin, but not collagen, is dependent on synergistic autocrine stimulation, particularly through secreted ADP. Selheim F; Idsøe R; Fukami MH; Holmsen H; Vassbotn FS Biochem Biophys Res Commun; 1999 Oct; 263(3):780-5. PubMed ID: 10512757 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents. Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of human platelet aggregation by eosinophils. Maziero AM; Lorenzetti R; Donato JL; Lilla S; De Nucci G Life Sci; 2013 Sep; 93(9-11):416-22. PubMed ID: 23871985 [TBL] [Abstract][Full Text] [Related]
33. Thrombin-induced platelet reactions: effect of substrates and inhibitors on binding of thrombin and serotonin release. Iwamoto M; Blombäck B Thromb Res; 1984 Feb; 33(4):427-37. PubMed ID: 6538704 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of thrombin binding and serotonin secretion from platelets by a 74,000 dalton protein. Ganguly P; Fossett NG Biochem Biophys Res Commun; 1983 Apr; 112(1):228-34. PubMed ID: 6838608 [TBL] [Abstract][Full Text] [Related]
35. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591 [TBL] [Abstract][Full Text] [Related]
36. [Effect of heparin on platelet aggregation in vitro]. Róka L; Isert D Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949 [TBL] [Abstract][Full Text] [Related]
37. A method for investigating the role of calcium in the shape change, aggregation and serotonin release of rat platelets. Belville JS; Bennett WF; Lynch G J Physiol; 1979 Dec; 297(0):289-97. PubMed ID: 536914 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the distinct mechanism of agonist-induced canine platelet activation. Chaudhary PK; Kim S J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187 [TBL] [Abstract][Full Text] [Related]
39. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting. Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041 [TBL] [Abstract][Full Text] [Related]
40. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide. Rendu F; Bachelot C; Molle D; Caen J; Guez D J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]